ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

Singapore SARS survivors yield hope for COVID super vaccine

Pfizer recipients found with 'highly potent' antibodies to respiratory viruses

A vial of the Pfizer vaccine in Singapore: A study found former SARS patients inoculated with the shot showed antibodies "capable of neutralizing not only all known SARS-CoV-2 variants of concern but also other animal coronaviruses."   © Reuters
DYLAN LOH, Nikkei staff writer | Singapore

SINGAPORE -- Survivors who lived through the SARS crisis in Singapore nearly two decades ago may yield hope for the development of a super vaccine to combat potent COVID-19 variants and even other coronaviruses, new research shows.

Read Next

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

Accept & Continue Close